ReviewClinical, cosmetic and investigational dermatology2018

Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.

Olabola Awosika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.